Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
QuintilesIMS
Federal Trade Commission
Daiichi Sankyo
Boehringer Ingelheim
Dow
Covington
Moodys
Deloitte
Mallinckrodt

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,404,215

« Back to Dashboard

Which drugs does patent 8,404,215 protect, and when does it expire?

Patent 8,404,215 protects RAVICTI and is included in one NDA.

This patent has twenty-one patent family members in twenty-one countries.
Summary for Patent: 8,404,215
Title:Methods of therapeutic monitoring of nitrogen scavenging
Abstract: The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods that utilize this technique to adjust the dosage of a nitrogen scavenging drug, determine whether to administer a nitrogen scavenging drug, and treat nitrogen retention disorders.
Inventor(s): Scharschmidt; Bruce (San Francisco, CA), Mokhtarani; Masoud (Walnut Creek, CA)
Assignee: Hyperion Therapeutics, Inc. (South San Francisco, CA)
Application Number:13/417,137
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 8,404,215

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Horizon Theraps Inc RAVICTI glycerol phenylbutyrate LIQUID;ORAL 203284-001 Feb 1, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up DOSAGE ADJUSTMENT OF A NITROGEN SCAVENGING DRUG IN THE TREATMENT OF A UREA CYCLE DISORDER ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,404,215

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,095,559 Methods of therapeutic monitoring of nitrogen scavenging drugs ➤ Sign Up
9,254,278 Methods of therapeutic monitoring of nitrogen scavenging drugs ➤ Sign Up
9,326,966 Methods of therapeutic monitoring of nitrogen scavenging drugs ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,404,215

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Cyprus 1119028 ➤ Sign Up
European Patent Office 2760479 ➤ Sign Up
European Patent Office 3263102 ➤ Sign Up
Spain 2629859 ➤ Sign Up
Croatia P20171063 ➤ Sign Up
Israel 231732 ➤ Sign Up
Japan 2014532179 ➤ Sign Up
Japan 6073898 ➤ Sign Up
Japan 2017067791 ➤ Sign Up
South Korea 20140094517 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Argus Health
Covington
Deloitte
Federal Trade Commission
QuintilesIMS
Express Scripts
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot